Gene mapping may unlock new cancer treatments for kids

NCT ID NCT02613962

Completed Knowledge-focused Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Apr 07, 2026 · Last updated May 23, 2026 · Updated 9 times

Summary

This study looked at tumors from 791 children whose cancers had come back or stopped responding to standard treatments. Researchers used advanced genetic testing to find specific changes in each child's tumor that could be targeted by existing drugs. The goal was to see how many children could be matched to a personalized treatment plan based on their tumor's unique genetic profile.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY PEDIATRIC TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Fondazione IRCCS Istituto

Milan, 20133, Italy
Gustave Roussy

Villejuif, Val de Marne, 94805, France
Hospital Universitari Vall D'Hebron

Barcelona, Catalonia, 08035, Spain
Our Lady's Children's Hospital

Dublin, Crumlin, 12, Ireland
Schneider Children's Medical Center

Petah Tikva, 49202, Israel

Conditions

Explore the condition pages connected to this study.

RELAPSED OR REFRACTORY PEDIATRIC TUMOR